We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 2 of 2
Most popular |Most recent

First Circuit Affirms Dismissal of Securities Class Action Against Biogen Inc.

USA - May 15 2017 On May 12, 2017, the U.S. Court of Appeals for the First Circuit affirmed dismissal of the putative securities class action In re Biogen Inc...

James R. Carroll, Michael S. Hines.

U.S. v. Novartis: reaffirming the importance of updating and adhering to corporate policies

USA - November 18 2014 A recent decision in a False Claims Act case, United States ex rel. Bilotta v. Novartis Pharmaceuticals Corporation (Novartis), underscores the...

Matthew J. Matule, Alexandra M. Gorman, Michael K. Loucks.